biologic

N/A

Hematopoietic Progenitor Cells, Cord (HPC-C)

Loss of exclusivityJune 2030projected — 12-year biologic exclusivity estimate

CompanyMD Anderson Cord Blood Bank

Drug detail

Brand name	N/A
Active ingredient	Hematopoietic Progenitor Cells, Cord (HPC-C)
Strength	2.5X10E7/KG CELL/ML
Dosage form	Injection
Route	Intravenous
Modality	Biologic
FDA approval	June 2018
Marketing status	Rx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.